These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 9066654)
1. Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas. Satoh K; Shimosegawa T; Koizumi M; Toyota T Anticancer Res; 1997; 17(1A):215-9. PubMed ID: 9066654 [TBL] [Abstract][Full Text] [Related]
2. Differential expression of CD44 splice variants in human pancreatic adenocarcinoma and in normal pancreas. Gansauge F; Gansauge S; Zobywalski A; Scharnweber C; Link KH; Nussler AK; Beger HG Cancer Res; 1995 Dec; 55(23):5499-503. PubMed ID: 7585621 [TBL] [Abstract][Full Text] [Related]
3. CD44 isoforms expression in intraductal and invasive pancreatic cancer and its correlation to p53 gene mutations. Tomaszewska R; Nowak K; Stachura J Pol J Pathol; 1999; 50(3):145-53. PubMed ID: 10624116 [TBL] [Abstract][Full Text] [Related]
4. Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines. Stickeler E; Runnebaum IB; Möbus VJ; Kieback DG; Kreienberg R Anticancer Res; 1997; 17(3C):1871-6. PubMed ID: 9216637 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Heider KH; Dämmrich J; Skroch-Angel P; Müller-Hermelink HK; Vollmers HP; Herrlich P; Ponta H Cancer Res; 1993 Sep; 53(18):4197-203. PubMed ID: 7689929 [TBL] [Abstract][Full Text] [Related]
6. Expression of CD44 splice variants in normal respiratory epithelium and bronchial carcinomas: no evidence for altered CD44 splicing in metastasis. Givehchian M; Woerner SM; Lacroix J; Zöller M; Drings P; Becker H; Kayser K; Ridder R; von Knebel Doeberitz M Oncogene; 1996 Mar; 12(5):1137-44. PubMed ID: 8649806 [TBL] [Abstract][Full Text] [Related]
7. Splice variants of CD44 in human cervical cancer stage IB to IIB. Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775 [TBL] [Abstract][Full Text] [Related]
8. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression. Lu D; Tawfik O; Pantazis C; Hobart W; Chapman J; Iczkowski K Gynecol Oncol; 1999 Oct; 75(1):84-90. PubMed ID: 10502431 [TBL] [Abstract][Full Text] [Related]
9. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884 [TBL] [Abstract][Full Text] [Related]
10. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance. Nguyen VN; Mirejovský T; Melinová L; Mandys V Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866 [TBL] [Abstract][Full Text] [Related]
11. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium. Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903 [TBL] [Abstract][Full Text] [Related]
12. Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer. Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Cosio S; Prontera C; Bianchi R; Genazzani AR Anticancer Res; 1997; 17(6D):4463-6. PubMed ID: 9494551 [TBL] [Abstract][Full Text] [Related]
13. CD44 in normal human pancreas and pancreatic carcinoma cell lines. Ringel J; Jesnowski R; Schmidt C; Ringel J; Köhler HJ; Rychly J; Batra SK; Löhr M Teratog Carcinog Mutagen; 2001; 21(1):97-106. PubMed ID: 11135324 [TBL] [Abstract][Full Text] [Related]
14. CD44 expression in sinonasal melanomas: is loss of isoform expression associated with advanced tumour stage? Regauer S; Ott A; Berghold A; Beham A J Pathol; 1999 Jan; 187(2):184-90. PubMed ID: 10365093 [TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study. Godge PY; Poonja LS Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of CD44 variants 6 and 7 in human endometrial cancer. Katsura M; Furumoto H; Nishimura M; Kamada M; Aono T Gynecol Oncol; 1998 Nov; 71(2):185-9. PubMed ID: 9826458 [TBL] [Abstract][Full Text] [Related]
17. Invasive cribriform breast carcinomas in patients with grade 1 and stage IIA (T2 N0 M0) breast cancer strongly express the v3 and v6, but not the v4 isoforms of the metastatic marker CD44. Saleh F; Reno W Neoplasma; 2008; 55(3):246-55. PubMed ID: 18348657 [TBL] [Abstract][Full Text] [Related]
18. Expression of CD44 variant isoforms in malignant melanoma. Seiter S; Schadendorf D; Herrmann K; Schneider M; Rösel M; Arch R; Tilgen W; Zöller M Clin Cancer Res; 1996 Mar; 2(3):447-56. PubMed ID: 9816190 [TBL] [Abstract][Full Text] [Related]
19. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice. Fichtner I; Dehmel A; Naundorf H; Finke LH Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216 [TBL] [Abstract][Full Text] [Related]
20. Splice variant expression of CD44 in patients with breast and ovarian cancer. Sanchez Lockhart M; Hajos SE; Basilio FM; Mongini C; Alvarez E Oncol Rep; 2001; 8(1):145-51. PubMed ID: 11115587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]